Skip to main content

Table 6 The geographic provenience of the samples previously detected with the mutation L1053X

From: Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer

SAMPLE geographic provenience

L1053X mutation frequency

Type

Cases

Age

The study highlighted the mutation

Sample source

Canada, USA and Poland*1

1 family (not specified)

Germline

Familial BC

-

Lubinski, et al. 2004 [18]

Research centers

UK, USA*2

1 control subject (not specified)

 

-

54

Song H, et al. 2014 [40]

Gayther SA, et al. 2007 [54]

Australia

1 case; as HRM High Resolution Melting Method validation

Method validation

Not specified

-

Hondow HL, et al. 2011 [53]

Peter MacCallum Cancer Centre and the Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)

UK, Netherlands*3

1 case

Germline

Prostate ca

54.6

Sandhu SK, et al. 2013 [39]

Fong PC, et al. 2009 [55]

UK

1 case

Germline

Prostate ca with family history of BC and Lung ca

46

Kote-Jarai Z, et al. 2011 [38]

Eeles RA, et al.1997 [56]

  1. *1Cancer centres where the sampling protocols including family pedigree were performed
  2. *2based on large population studies: the population-based SEARCH study UK and the hospital-based Mayo clinic study from USA
  3. *3The centers where the study was performed: at the Royal Marsden National Health Service (NHS) Foundation Trust (United Kingdom) and the Netherlands Cancer Institute (the Netherlands)